The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes
Open accessAbstract
Type 1 Diabetes (T1D) is an autoimmune disease characterized by the pancreatic infiltration of immune cells resulting in T cell-mediated destruction of the insulin-producing beta cells. The successes of the Non Obese Diabetic (NOD) mouse model have come in multiple forms including identifying key genetic and environmental risk factors e.g. Idd loci and effects of microorganisms including the gut microbiota, respectively, and how they may contribute to disease susceptibility and pathogenesis. Furthermore, the NOD model also provides insights into the roles of the innate immune cells as well as the B cells in contributing to the T cell-mediated disease. Unlike many autoimmune disease models, the NOD mouse develops spontaneous disease and has many similarities to human T1D. Through exploiting these similarities many targets have been identified for immune-intervention strategies. Although many of these immunotherapies did not have a significant impact on human T1D, they have been shown to be effective in the NOD mouse in early stage disease, which is not equivalent to trials in newly-diagnosed patients with diabetes. However, the continued development of humanized NOD mice would enable further clinical developments, bringing T1D research to a new translational level. Therefore, it is the aim of this review to discuss the importance of the NOD model in identifying the roles of the innate immune system and the interaction with the gut microbiota in modifying diabetes susceptibility. In addition, the role of the B cells will also be discussed with new insights gained through B cell depletion experiments and the impact on translational developments. Finally, this review will also discuss the future of the NOD mice and the development of humanized NOD mice, providing novel insights into human T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Self-citationNOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Breeding of a Non-Obese, Diabetic Strain of Mice
MAKINO, S., KUNIMOTO, K., MURAOKA, Y., MIZUSHIMA, Y., KATAGIRI, K., & TOCHINO, Y. (1980) · Experimental Animals · doi:10.1538/expanim1978.29.1_1 · Cited by 1,249
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085
Takeuchi, O., Hoshino, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5392 · Cited by 1,048
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Diabetes in identical twins: A study of 200 pairs
Barnett, A. H., Eff, C., Leslie, R. D. G., & Pyke, D. A. (1981) · Diabetologia · doi:10.1007/bf00262007 · Cited by 959
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Akashi, K., Shultz, L. D., & Harada, M. (2005) · Blood · doi:10.1182/blood-2005-02-0516 · Cited by 932
Function of Nod‐like receptors in microbial recognition and host defense
Franchi, L., Warner, N., Viani, K., & Nuñez, G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00734.x · Cited by 903
HL-A ANTIGENS AND DIABETES MELLITUS
Nerup, J., Platz, P., Andersen, O. O., Christy, M., Lyngsøe, J., Poulsen, J. E., Ryder, L. P., Thomsen, M., Nielsen, L. S., & Svejgaard, A. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91201-x · Cited by 818
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809 · cited 1×
“Upstream of the proinsulin gene are a variable number of tandem repeats (VNTRs), which, depending on the number present, determine if the individual is protected from (140–200+ repeats, associated with increased thymic proinsulin) or susceptible to (26–63 repeats, associated with reduced thymic expression) diabetes [7…”
BackgroundHLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790 · cited 1×
“In humans, the DR3/4-DQ2/8 haplotypes provide the greatest susceptibility to T1D [70], with other DR and DQ alleles providing protection [71].”
BackgroundDevelopment and function of human innate immune cells in a humanized mouse model
Rongvaux, A., Willinger, T., Martinek, J., Strowig, T., Gearty, S. V., Teichmann, L. L., Saito, Y., Marches, F., Halene, S., Palucka, A. K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2858 · Cited by 789
Variation and trends in incidence of childhood diabetes in Europe
(2000) · The Lancet · doi:10.1016/s0140-6736(99)07125-1 · Cited by 755
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
A Molecular Basis for MHC Class II—Associated Autoimmunity
Todd, J. A., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., et al. (1988) · Science · doi:10.1126/science.3368786 · Cited by 705
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
Harjutsalo, V., Sjöberg, L., & Tuomilehto, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60765-5 · Cited by 666
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H., & Shultz, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2049 · Cited by 583
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
The Wellcome Trust Case Control Consortium, Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J., Field, S. F., Stevens, H. E., Reynolds, P., Hardy, M., King, E., et al. (2007) · Nature · doi:10.1038/nature06406 · Cited by 570
Gale, E. A. M., & Gillespie, K. M. (2001) · Diabetologia · doi:10.1007/s001250051573 · Cited by 558
Ochoa-Repáraz, J., Mielcarz, D. W., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.29 · Cited by 507
Hansen, C. H. F., Krych, L., Nielsen, D. S., Vogensen, F. K., Hansen, L. H., Sørensen, S. J., Buschard, K., & Hansen, A. K. (2012) · Diabetologia · doi:10.1007/s00125-012-2564-7 · Cited by 500
The “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Sherry, N., Hagopian, W., Ludvigsson, J., Jain, S. M., Wahlen, J., Ferry, R. J., Bode, B., Aronoff, S., Holland, C., Carlin, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60931-8 · Cited by 493
Cario, E., Gerken, G., & Podolsky, D. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.015 · Cited by 475
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Fukata, M., Chen, A., Klepper, A., Krishnareddy, S., Vamadevan, A. S., Thomas, L. S., Xu, R., Inoue, H., Arditi, M., Dannenberg, A. J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.017 · Cited by 455
Christianson, S. W., Shultz, L. D., & Leiter, E. H. (1993) · Diabetes · doi:10.2337/diab.42.1.44 · Cited by 438
Wong, F. S., Karttunen, J., Dumont, C., Wen, L., Visintin, I., Pilip, I. M., Shastri, N., Pamer, E. G., & Janeway, C. A. (1999) · Nature Medicine · doi:10.1038/12465 · Cited by 430
Self-citationDiana, J., Simoni, Y., Furio, L., Beaudoin, L., Agerberth, B., Barrat, F., & Lehuen, A. (2013) · Nature Medicine · doi:10.1038/nm.3042 · Cited by 427
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Hu, C.-Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J., & Wen, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32405 · Cited by 426
Self-citationThe NOD Mouse: Recessive Diabetogenic Gene in the Major Histocompatibility Complex
Hattori, M., Buse, J. B., Jackson, R. A., Glimcher, L., Dorf, M. E., Minami, M., Makino, S., Moriwaki, K., Kuzuya, H., Imura, H., et al. (1986) · Science · doi:10.1126/science.3003909 · Cited by 418
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
Chatenoud, L., Primo, J., & Bach, J. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2947 · Cited by 417
The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies
Nakhooda, A. F., Like, A. A., Chappel, C. I., Murray, F. T., & Marliss, E. B. (1977) · Diabetes · doi:10.2337/diab.26.2.100 · Cited by 416
Singal, D. P., & Blajchman, M. A. (1973) · Diabetes · doi:10.2337/diab.22.6.429 · Cited by 412
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells
Krutzik, S. R., Tan, B., Li, H., Ochoa, M. T., Liu, P. T., Sharfstein, S. E., Graeber, T. G., Sieling, P. A., Liu, Y.-J., Rea, T. H., et al. (2005) · Nature Medicine · doi:10.1038/nm1246 · Cited by 404
Horai, R., Zárate-Bladés, C. R., Dillenburg-Pilla, P., Chen, J., Kielczewski, J. L., Silver, P. B., Jittayasothorn, Y., Chan, C.-C., Yamane, H., Honda, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.014 · Cited by 402
The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.
Acha-Orbea, H., & McDevitt, H. O. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2435 · Cited by 398
Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs
Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., & Tuomilehto, J. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1052 · Cited by 394
Lieberman, S. M., Evans, A. M., Han, B., Takaki, T., Vinnitskaya, Y., Caldwell, J. A., Serreze, D. V., Shabanowitz, J., Hunt, D. F., Nathenson, S. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932778100 · Cited by 388
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease
Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B., Conrad, C., Ittner, L. M., Bauer, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1176 · Cited by 378
Yan, H. H., Pickup, M., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 372
Elias, D., Reshef, T., Birk, O. S., van der Zee, R., Walker, M. D., & Cohen, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3088 · Cited by 371
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001443 · Cited by 367
Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
Wong, F. S., Visintin, I., Wen, L., Flavell, R. A., & Janeway, C. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.67 · Cited by 346
Self-citationNOD2/CARD15 Mediates Induction of the Antimicrobial Peptide Human Beta-defensin-2
Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schröder, J. M., & Harder, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511044200 · Cited by 344
Chromogranin A is an autoantigen in type 1 diabetes
Stadinski, B. D., Delong, T., Reisdorph, N., Reisdorph, R., Powell, R. L., Armstrong, M., Piganelli, J. D., Barbour, G., Bradley, B., Crawford, F., et al. (2010) · Nature Immunology · doi:10.1038/ni.1844 · Cited by 338
Noble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335
Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., et al. (1990) · Nature · doi:10.1038/345727a0 · Cited by 331
Uehara, A., Fujimoto, Y., Fukase, K., & Takada, H. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.007 · Cited by 330
Jansen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, P. J., Dardenne, M., & Drexhage, H. A. (1994) · Diabetes · doi:10.2337/diab.43.5.667 · Cited by 330
Redondo, M. J., Yu, L., Hawa, M., Mackenzie, T., Pyke, D. A., Eisenbarth, G. S., & Leslie, R. D. G. (2001) · Diabetologia · doi:10.1007/s001250051626 · Cited by 322
The Role of Antimicrobial Peptides in Innate Immunity
Ganz, T. (2003) · Integrative and Comparative Biology · doi:10.1093/icb/43.2.300 · Cited by 320
COOKE, A., TONKS, P., JONES, F. M., O'SHEA, H., HUTCHINGS, P., FULFORD, A. J. C., & DUNNE (1999) · Parasite Immunology · doi:10.1046/j.1365-3024.1999.00213.x · Cited by 315
A review of the current use of rituximab in autoimmune diseases
Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.004 · Cited by 314
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 306
Gillespie, K. M., Bain, S. C., Barnett, A. H., Bingley, P. J., Christie, M. R., Gill, G. V., & Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17357-1 · Cited by 304
Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice
Nishimoto, H., Kikutani, H., Yamamura, K.-I., & Kishimoto, T. (1987) · Nature · doi:10.1038/328432a0 · Cited by 301
Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D., & Roopenian, D. C. (1994) · Diabetes · doi:10.2337/diab.43.3.505 · Cited by 301
Brehm, M. A., Cuthbert, A., Yang, C., Miller, D. M., DiIorio, P., Laning, J., Burzenski, L., Gott, B., Foreman, O., Kavirayani, A., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.008 · Cited by 273
TLR signaling in B-cell development and activation
Hua, Z., & Hou, B. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.61 · Cited by 269
Insulin Expression Levels in the Thymus Modulate Insulin-Specific Autoreactive T-Cell Tolerance
Chentoufi, A. A., & Polychronakos, C. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1383 · Cited by 264
Extreme genetic risk for type 1A diabetes
Aly, T. A., Ide, A., Jahromi, M. M., Barker, J. M., Fernando, M. S., Babu, S. R., Yu, L., Miao, D., Erlich, H. A., Fain, P. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606349103 · Cited by 257
Hiramatsu, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Katamura, K., & Nakahata, T. (2003) · Blood · doi:10.1182/blood-2002-09-2755 · Cited by 254
Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice
Serreze, D. V., Gaskins, H. R., & Leiter, E. H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2534 · Cited by 246
Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., Nonaka, K., & Tarui, S. (1985) · PubMed Central · Cited by 235
β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes
Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., Podolin, P. L., Zijlstra, M., Jaenisch, R., & Peterson, L. B. (1994) · Diabetes · doi:10.2337/diab.43.3.500 · Cited by 235
Evidence for Initial Involvement of Macrophage in Development of Insulitis in NOD Mice
Lee, K.-U., Amano, K., & Yoon, J.-W. (1988) · Diabetes · doi:10.2337/diab.37.7.989 · Cited by 235
Intracellular NOD-like receptors in innate immunity, infection and disease
Franchi, L., Park, J.-H., Shaw, M. H., Marina-Garcia, N., Chen, G., Kim, Y.-G., & Núñez, G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01059.x · Cited by 231
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. W., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · PubMed · Cited by 229
The role of CD8+ T cells in the initiation of insulin‐dependent diabetes mellitus
Wang, B., Gonzalez, A., Benoist, C., & Mathis, D. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260815 · Cited by 223
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. S., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.743 · Cited by 210
Shang, L., Fukata, M., Thirunarayanan, N., Martin, A. P., Arnaboldi, P., Maussang, D., Berin, C., Unkeless, J. C., Mayer, L., Abreu, M. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.020 · Cited by 204
Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group.
(2000) · PubMed · Cited by 202
Takiishi, T., Korf, H., Van Belle, T. L., Robert, S., Grieco, F. A., Caluwaerts, S., Galleri, L., Spagnuolo, I., Steidler, L., Van Huynegem, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60530 · Cited by 201
Toll-like Receptor 2 Senses β-Cell Death and Contributes to the Initiation of Autoimmune Diabetes
Kim, H. S., Han, M. S., Chung, K. W., Kim, S., Kim, E., Kim, M. J., Jang, E., Lee, H. A., Youn, J., Akira, S., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.010 · Cited by 195
Kollet, O., Peled, A., Byk, T., Ben-Hur, H., Greiner, D., Shultz, L., & Lapidot, T. (2000) · Blood · doi:10.1182/blood.v95.10.3102 · Cited by 183
DiLorenzo, T. P., Graser, R. T., Ono, T., Christianson, G. J., Chapman, H. D., Roopenian, D. C., Nathenson, S. G., & Serreze, D. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12538 · Cited by 181
Penaranda, C., Tang, Q., & Bluestone, J. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100713 · Cited by 176
MATSUZAKI, T., NAGATA, Y., KADO, S., UCHIDA, K., KATO, I., HASHIMOTO, S., & YOKOKURA, T. (1997) · APMIS · doi:10.1111/j.1699-0463.1997.tb05066.x · Cited by 175
Yi, H., Guo, C., Yu, X., Zuo, D., & Wang, X.-Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200086 · Cited by 174
Saxena, V., Ondr, J. K., Magnusen, A. F., Munn, D. H., & Katz, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5041 · Cited by 170
King, M., Pearson, T., Shultz, L. D., Leif, J., Bottino, R., Trucco, M., Atkinson, M. A., Wasserfall, C., Herold, K. C., Woodland, R. T., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.001 · Cited by 169
Nagata, M., Santamaria, P., Kawamura, T., Utsugi, T., & Yoon, J. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.2042 · Cited by 161
Serreze, D. V., Gaedeke, J. W., & Leiter, E. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9625 · Cited by 160
Robert, S., Gysemans, C., Takiishi, T., Korf, H., Spagnuolo, I., Sebastiani, G., Van Huynegem, K., Steidler, L., Caluwaerts, S., Demetter, P., et al. (2014) · Diabetes · doi:10.2337/db13-1236 · Cited by 160
Suri, A., Walters, J. J., Gross, M. L., & Unanue, E. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25350 · Cited by 159
Long term effect of gut microbiota transfer on diabetes development
Peng, J., Narasimhan, S., Marchesi, J. R., Benson, A., Wong, F. S., & Wen, L. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.03.005 · Cited by 158
Self-citationThe BB Diabetic Rat: Profound T-Cell Lymphocytopenia
Jackson, R., Rassi, N., Crump, T., Haynes, B. F., & Eisenbarth, G. S. (1981) · Diabetes · doi:10.2337/diab.30.10.887 · Cited by 157
Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice
Hulbert, C., Riseili, B., Rojas, M., & Thomas, J. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5535 · Cited by 153
Yagi, H., Matsumoto, M., Kunimoto, K., Kawaguchi, J., Makino, S., & Harada, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220931 · Cited by 149
Drescher, K. M., Kono, K., Bopegamage, S., Carson, S. D., & Tracy, S. (2004) · Virology · doi:10.1016/j.virol.2004.06.049 · Cited by 149
The contribution of direct TLR signaling to T cell responses
Rahman, A. H., Taylor, D. K., & Turka, L. A. (2009) · Immunologic Research · doi:10.1007/s12026-009-8113-x · Cited by 143
Marietta, E. V., Gomez, A. M., Yeoman, C. J., Tilahun, A. Y., Clark, C. R., Luckey, D. H., Murray, J. A., White, B. A., Kudva, Y. C., & Rajagopalan, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078687 · Cited by 143
Richer, M. J., Lavallée, D. J., Shanina, I., & Horwitz, M. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004127 · Cited by 140
Hu, C., Ding, H., Li, Y., Pearson, J. A., Zhang, X., Flavell, R. A., Wong, F. S., & Li, W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513509112 · Cited by 140
Self-citationIrwin, M. J., Heath, W. R., & Sherman, L. A. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.4.1091 · Cited by 136
TLR Activation Synergizes with Kilham Rat Virus Infection to Induce Diabetes in BBDR Rats
Zipris, D., Lien, E., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.131 · Cited by 131
Bergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012) · Diabetes · doi:10.2337/db11-1263 · Cited by 125
Takaki, T., Marron, M. P., Mathews, C. E., Guttmann, S. T., Bottino, R., Trucco, M., DiLorenzo, T. P., & SERREZE, D. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3257 · Cited by 122
Gaudreau, S., Guindi, C., Ménard, M., Besin, G., Dupuis, G., & Amrani, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3638 · Cited by 119
Tormo-Badia, N., Håkansson, Å., Vasudevan, K., Molin, G., Ahrné, S., & Cilio, C. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12205 · Cited by 116
Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?
Chatenoud, L. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.275 · Cited by 114
Dendritic Cells and Scavenger Macrophages in Pancreatic Islets of Prediabetic BB Rats
Voorbij, H. A. M., Jeucken, P. H. M., Kabel, P. J., de Haan-Meulman, M., & Drexhage, H. A. (1989) · Diabetes · doi:10.2337/diab.38.12.1623 · Cited by 108
Hutchings, P. R., Reilly, L. O., Parish, N. M., Waldmann, H., & Cooke, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220735 · Cited by 104
Li, W., Wong, F. S., Tang, J., Chen, N., Altieri, M., David, C. S., Flavell, R. A., & Sherwin, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.97 · Cited by 103
Self-citationTeplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
Waldron-Lynch, F., Henegariu, O., Deng, S., Preston‐Hurlburt, P., Tooley, J., Flavell, R. A., & Herold, K. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003401 · Cited by 100
Nikolić, T., Geutskens, S. B., van Rooijen, N., Drexhage, H. A., & Leenen, P. J. M. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700238 · Cited by 96
NOD Mouse Diabetes: The Ubiquitous Mouse Hsp60 is a β-Cell Target Antigen of Autoimmune T Cells
Birk, O. S., Elias, D., Weiss, A. S., Rosen, A., van der Zee, R., WALKER, M. D., & Cohen, I. R. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0019 · Cited by 95
On the Pathogenicity of Autoantigen-Specific T-Cell Receptors
Burton, A. R., Vincent, E., Arnold, P. Y., Lennon, G. P., Smeltzer, M. P., Li, C., HASKINS, K. M., Hutton, J. C., Tisch, R., Sercarz, E. E., et al. (2008) · Diabetes · doi:10.2337/db07-1129 · Cited by 95
Chao, C., Sytwu, H., Chen, E. L., Toma, J., & McDevitt, H. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9299 · Cited by 94
Yoshino, H., Ueda, T., Kawahata, M., Kobayashi, K., Ebihara, Y., Manabe, A., Tanaka, R., Ito, M., Asano, S., Nakahata, T., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702702 · Cited by 91
Herold, K. C., Pescovitz, M. D., McGee, P., Krause-Steinrauf, H. J., Spain, L. M., Bourcier, K., Asare, A. L., Liu, Z., Lachin, J. M., Dosch, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100539 · Cited by 85
Acevedo‐Suárez, C. A., Hulbert, C., Woodward, E. J., & Thomas, J. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.827 · Cited by 83
Steptoe, R. J., Ritchie, J. M., & Harrison, L. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5032 · Cited by 81
Diabetogenic T cells are primed both in pancreatic and gut‐associated lymph nodes in NOD mice
Jaakkola, I., Jalkanen, S., & Hänninen, A. L. M. (2003) · European Journal of Immunology · doi:10.1002/eji.200324405 · Cited by 81
Development of Insulitis and Diabetes in B Cell-Deficient NOD Mice
Yang, M., Charlton, B., & Gautam, A. M. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0128 · Cited by 80
TLR9 Blockade Inhibits Activation of Diabetogenic CD8+ T Cells and Delays Autoimmune Diabetes
Zhang, Y., Lee, A. S., Shameli, A., Geng, X., Finegood, D. T., Santamaría, P., & Dutz, J. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901814 · Cited by 80
Are Insights Gained from NOD Mice Sufficient to Guide Clinical Translation?
Roep, B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.018 · Cited by 77
Identification of Naturally Processed HLA-A2—Restricted Proinsulin Epitopes by Reverse Immunology
Hassainya, Y., Garcia‐Pons, F., Kratzer, R., Lindo, V., Greer, F. M., Lemonnier, F. A., Niedermann, G., & Endert, P. V. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2053 · Cited by 74
Unger, W. W. J., Pearson, T., Abreu, J. R. F., Laban, S., van der Slik, A. R., der Kracht, S. M.-V., Kester, M. G. D., SERREZE, D. V., Shultz, L. D., Griffioen, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049213 · Cited by 72
The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model
Li, W., Chen, N., Tang, J., Sherwin, R., & Wong, F. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11708 · Cited by 71
Self-citationInhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse
Zekzer, D., Wong, F. S., Li, W., Altieri, M., Gurlo, T., von Grafenstein, H., & Sherwin, R. S. (1997) · Diabetes · doi:10.2337/diab.46.7.1124 · Cited by 69
Self-citationThe Role of Toll‐Like Receptors 3 and 9 in the Development of Autoimmune Diabetes in NOD Mice
Wong, F. S., Hu, C., Zhang, L., Du, W., Alexopoulou, L., Flavell, R. A., & Li, W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.039 · Cited by 66
Self-citationDelayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice
Schmid, S., Koczwara, K., Schwinghammer, S., Lampasona, V., Ziegler, A., & Bonifacio, E. E. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.012 · Cited by 66
Gülden, E., Ihira, M., Ohashi, A., Reinbeck, A. L., Freudenberg, M. A., Kolb, H., & Burkart, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075385 · Cited by 66
Makhlouf, L., Grey, S. T., Dong, V. M., Csizmadia, E., Arvelo, M. B., Auchincloss, H., Ferran, C. J., & Sayegh, M. H. (2004) · Transplantation · doi:10.1097/01.tp.0000118410.61419.59 · Cited by 65
Abiru, N., Wegmann, D. R., Kawasaki, E., Gottlieb, P. A., Simone, E. A., & Eisenbarth, G. S. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0369 · Cited by 64
Awata, T., Guberski, D. L., & Like, A. A. (1995) · Endocrinology · doi:10.1210/en.136.12.5731 · Cited by 60
Evertsen, J. M., Alemzadeh, R., & Wang, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006873 · Cited by 59
Epidemiological Perspectives on Type 1 Diabetes in Childhood and Adolescence in Germany
Ehehalt, S., Dietz, K., Willasch, A. M., Neu, A., & for the Baden-Württemberg Diabetes Incidence Registry (DIARY) Group (2009) · Diabetes Care · doi:10.2337/dc09-1503 · Cited by 59
Combination Treatment With Anti-CD20 and Oral Anti-CD3 Prevents and Reverses Autoimmune Diabetes
Hu, C., Ding, H., Zhang, X., Wong, F. S., & Li, W. (2013) · Diabetes · doi:10.2337/db12-1175 · Cited by 58
Self-citationAutoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes
Bonami, R. H., Kendall, P. L., & Thomas, J. W. (2012) · Diabetes · doi:10.2337/db11-1746 · Cited by 56
Pontesilli, O., Carotenuto, P., Gazda, L. S., Pratt, P. F., & Prowse, S. J. (1987) · PubMed · Cited by 55
Li, W., Wong, F. S., Burkly, L. C., Altieri, M., Mamalaki, C., Kioussis, D., Flavell, R. A., & Sherwin, R. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2723 · Cited by 55
Self-citationLiu, J., Purdy, L., Rabinovitch, S., Jevnikar, A. M., & Elliott, J. F. (1999) · Diabetes · doi:10.2337/diabetes.48.3.469 · Cited by 55
Robles, D. T., Eisenbarth, G. S., Garnes, N. D., Peterson, L. B., & Wicker, L. S. (2003) · Diabetes · doi:10.2337/diabetes.52.3.882 · Cited by 54
Peritoneal B cells govern the outcome of diabetes in non‐obese diabetic mice
Kendall, P. L., Woodward, E. J., Hulbert, C., & Thomas, J. W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324744 · Cited by 52
Alkanani, A. K., Hara, N., Lien, E., Ir, D., Kotter, C. V., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2013) · Diabetes · doi:10.2337/db13-1007 · Cited by 52
A Humanized Mouse Model of Autoimmune Insulitis
Milam, A. A. V., Maher, S. E., Gibson, J. A., Lebastchi, J., Li, W., Ruddle, N. H., Herold, K. C., & Bothwell, A. L. M. (2014) · Diabetes · doi:10.2337/db13-1141 · Cited by 47
Tai, N., Wong, F. S., & Li, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300547 · Cited by 46
Self-citationBouma, G., Coppens, J. M. C., Mourits, S., Nikolić, T., Sozzani, S., Drexhage, H. A., & Versnel, M. A. (2005) · European Journal of Immunology · doi:10.1002/eji.200526251 · Cited by 43
Kendall, P. L., Moore, D. J., Hulbert, C., Hoek, K. L., Khan, W. N., & Thomas, J. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900367 · Cited by 39
Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice
van Halteren, A. G. S., Kardol, M. J., Mulder, A., & Roep, B. O. (2004) · Diabetologia · doi:10.1007/s00125-004-1613-2 · Cited by 39
Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden
Hjern, A., & Söderström, U. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00267.x · Cited by 38
Toll-Like Receptor 3 Is Critical for Coxsackievirus B4-Induced Type 1 Diabetes in Female NOD Mice
McCall, K. D., Thuma, J. R., Courreges, M. C., Benencia, F., James, C., Malgor, R., Kantake, N., Mudd, W., Denlinger, N., Nolan, B., et al. (2014) · Endocrinology · doi:10.1210/en.2013-2006 · Cited by 36
Wong, A. S. L., Mortin-Toth, S. M., Sung, M., Canty, A. J., Gulban, O., Greaves, D. R., & Danska, J. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401984 · Cited by 35
Yi, Z., Diz, R., Martin, A. J., Morillon, Y. M., Kline, D. E., Li, L., Wang, B., & Tisch, R. (2012) · Diabetes · doi:10.2337/db12-0098 · Cited by 35
Li, Y., Zhou, L., Li, Y., Zhang, J., Guo, B., Meng, G., Chen, X., Zheng, Q., Zhang, L., Zhang, M., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.04.017 · Cited by 34
Niens, M., Grier, A. E., Marron, M. P., Kay, T. W. H., Greiner, D. L., & SERREZE, D. V. (2011) · Diabetes · doi:10.2337/db10-1523 · Cited by 34
Ejrnaes, M., Videbæk, N., Christen, U., Cooke, A., Michelsen, B. K., & von Herrath, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2746 · Cited by 34
Insulin autoantibodies in non-obese diabetic (NOD) mice.
Michel, C., Boîtard, C., & Bach, J. (1989) · PubMed · Cited by 33
Kim, D.-H., Lee, J.-C., Lee, M., Kim, K.-W., & Lee, M.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2723-x · Cited by 32
Bonami, R. H., Williams, J. M., Rachakonda, A., Karamali, M., Kendall, P. L., & Thomas, J. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201359 · Cited by 32
The Dual Effects of B Cell Depletion on Antigen-Specific T Cells in BDC2.5NOD Mice
Xiang, Y., Peng, J., Tai, N., Hu, C., Zhou, Z., Wong, F. S., & Li, W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103055 · Cited by 30
Self-citationIRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
Tan, Q., Majewska‐Szczepanik, M., Zhang, X., Szczepanik, M., Zhou, Z., Wong, F. S., & Li, W. (2014) · Diabetes · doi:10.2337/db13-1504 · Cited by 28
Self-citationPre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment
Belle, T. L. V., Juntti, T., Liao, J., & von Herrath, M. G. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.010 · Cited by 28
Mor, F., & Cohen, I. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215722110 · Cited by 28
An islet-homing NOD CD8+cytotoxic T cell clone recognizes GAD65and causes insulitis
Videbæk, N., Harach, S. Z., Phillips, J. M., Hutchings, P. R., Ozegbe, P., Michelsen, B. K., & Cooke, A. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00003-9 · Cited by 27
Nayak, D. K., Calderón, B., Vomund, A. N., & Unanue, E. R. (2014) · Diabetes · doi:10.2337/db13-1882 · Cited by 25
Sato, A. K., Sturniolo, T., Sinigaglia, F., & Stern, L. J. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00120-2 · Cited by 24
Myeloid-derived suppressor cells in immunity and autoimmunity
Yang, H., Bi, Y., Han, F., Lu, Y., Wang, J., Zhang, Z., & Liu, G. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1052794 · Cited by 23
[Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody].
Chatenoud, L., Thervet, É., Primo, J., & Bach, J. (1992) · PubMed · Cited by 22
Natural History of Humoral Immunity to Glutamic Acid Decarboxylase in Non-Obese Diabetic (NOD) Mice
Aizpurua, H. J. D., French, M. B., Chosich, N., & Harrison, L. C. (1994) · Journal of Autoimmunity · doi:10.1006/jaut.1994.1049 · Cited by 21
Kudva, Y. C., Deng, Y.-J., Govindarajan, R., Abraham, R. S., Marietta, E. V., Notkins, A. L., & David, C. S. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00308-1 · Cited by 21
GONNELLA, P. A., Waldner, H., del Nido, P. J., & McGowan, F. X. J. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.06.002 · Cited by 20
Welzen‐Coppens, J. M. C., van Helden-Meeuwsen, C. G., Leenen, P. J. M., Drexhage, H. A., & Versnel, M. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312168 · Cited by 20
Steinman, L., & Shoenfeld, Y. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.001 · Cited by 18
Abul Abbas: An epitome of scholarship
Gershwin, M. E., & Shoenfeld, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.07.006 · Cited by 16
Spatial Clustering in Childhood Diabetes: Evidence of an Environmental Cause
Bodington, M., Muzulu, S., & Burden, A. C. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00387.x · Cited by 15
Generation and maintenance of autoantigen-specific CD8+ T cell clones isolated from NOD mice
Bowie, L., Tite, J. P., & Cooke, A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00106-4 · Cited by 14
Antal, Z., Baker, J. C., Smith, C., Jarchum, I., Babad, J., Mukherjee, G., Yang, Y., Sidney, J., Sette, A., Santamaría, P., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102930 · Cited by 14
Nonobese Diabetic (NOD) Mouse Dendritic Cells Stimulate Insulin Secretion by Prediabetic Islets
Durant, S., Alvès, V., Coulaud, J., & Homo‐Delarche, F. (2002) · Autoimmunity · doi:10.1080/08916930 · Cited by 13
Islet Cell Autoimmunity in NOD Mice Transgenic for HLA-DQ8 and Lacking I-Ag7
Raju, R. P., Munn, S. R., Majoribanks, C., & David, C. S. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(97)01404-8 · Cited by 10
Beumer, W., Welzen‐Coppens, J. M. C., van Helden-Meeuwsen, C. G., Gibney, S. M., Drexhage, H. A., & Versnel, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103404 · Cited by 8
Sang, L. P., Majji, S., Casares, S. A., & Brumeanu, T. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27374 · Cited by 6
Cited by
Streptozotocin‐Induced Diabetic Models in Mice and Rats
Furman, B. L. (2021) · Current Protocols · doi:10.1002/cpz1.78 · Cited by 874
Neutrophils in chronic inflammatory diseases
Herrero-Cervera, A., Soehnlein, O., & Kenne, E. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00832-3 · Cited by 695
Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Thompson, P. J., Shah, A., Ntranos, V., Van Gool, F., Atkinson, M., & Bhushan, A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.021 · Cited by 353
Experimental Diabetes Mellitus in Different Animal Models
Al-awar, A., Kupai, K., Veszelka, M., Szűcs, G., Attieh, Z., Murlasits, Z., Török, S., Pósa, A., & Varga, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9051426 · Cited by 305
Guay, C., Kruit, J. K., Rome, S., Menoud, V., Mulder, N. L., Jurdzinski, A., Mancarella, F., Sebastiani, G., Donda, A., Gonzalez, B. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.011 · Cited by 286
Metadata
- Authors
- Pearson, J. A., Wong, F. S., & Wen, L.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 66
- Pages
- 76-88
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2202439768
- Cited by
- 298
- References
- 185
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.